SLNO
Soleno Therapeutics, Inc. Common StockData: 2026-05-15
Quick Stats
48.2
AI Score
HOLD0.95
Volume Ratio
TBA
Next Earnings
21
+ve Days (30d)
7
-ve Days (30d)
SLNO Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
SLNO Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
SLNO Options - Sort by Max open Interest (near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SLNO Daily Out of Money Options - Sort by Max open Interest (near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SLNO Daily In the Money Options - Sort by Max open Interest (near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SLNO Most Active Options by Volume(near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SLNO Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
SLNO Stock Summary
Last updated
SLNO is currently trading at $53.01, positioned below its 200-day moving average of $, suggesting bearish momentum. The stock has a 52-week range of $29.43 to $90.3199.
Technical Analysis: The 50-day moving average stands at $, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads , suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is , which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates SLNO at 48.2/100 with a HOLD recommendation.
SLNO Candlestick Patterns
No validated candlestick patterns fired for SLNO in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.
Soleno Therapeutics, Inc. Common Stock is below both the 50 Day and 200 Day SMA which is considered Bearish.
SLNO Moving Averages Analysis
SLNO (Soleno Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated
| Days | MA |
|---|
SLNO Fundamental Analysis
| P/E (Forward) | 13.1062 |
| P/E (Trailing) | 27.456 |
| Market Cap ($) | 2.8 billion |
| Earnings/Share ($) | 1.93 |
| Net Profit Margin (%) | 0.337 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 3.9483 |
| EPS Estimate Next Year ($) | 6.285 |
| WallStreet Target Price ($) | 53.00 |
| Most Recent Quarter |
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.